Iterion Therapeutics Inc.
Houston, TX
- UEI
- RGK8GNFJGWL1
- CAGE
- 6GLU8
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 7255 Helix Park Ave p3041, Houston, TX 77030, USA
- Website
- iteriontherapeutics.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Chronic intrapulmonary delivery of a novel small molecule WNT/beta-catenin inhibitor for idiopathic pulmonary fibrosis | National Heart Lung and Blood Institute (NIH) | $299,974 |
Quick answers
Is Iterion Therapeutics Inc. registered in SAM.gov?
Yes. Iterion Therapeutics Inc.'s SAM.gov registration is active through March 5, 2027.
What is Iterion Therapeutics Inc.'s most recent federal award?
Iterion Therapeutics Inc.'s most recent federal grant award is Chronic intrapulmonary delivery of a novel small molecule WNT/beta-catenin inhibitor for idiopathic pulmonary fibrosis (R41HL142357), from National Heart Lung and Blood Institute (NIH), on May 15, 2018.
On GovTribe
See Iterion Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors